Dmso_a_202193 1527..1541
Xiaohan Tang,Xiang Yan,Houde Zhou,Xilin Yang,Xiaohong Niu,Jia-jin Liu,Qiuhe Ji,Linong Ji,Xuri Li,Zhiguang Zhou
2019-01-01
Abstract:Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, People’s Republic of China; Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, Changsha, People’s Republic of China; National Clinical Research Center for Metabolic Diseases, Changsha, People’s Republic of China; Hunan Key Laboratory for Metabolic Bone Diseases, Changsha, People’s Republic of China; Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, People’s Republic of China; Department of Endocrinology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, People’s Republic of China; Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, People’s Republic of China; Department of Endocrinology, Xijing Hospital, Fourth Military Medical University, Xi'an, People’s Republic of China; Department of Endocrinology and Metabolism, Peking University People’s Hospital, Beijing, People’s Republic of China Aim: This study aimed to estimate the prevalence of latent autoimmune diabetes of adults (LADA) and classic type 1 diabetes mellitus (T1DM) in newly diagnosed adult diabetes in China. Method: This cross-sectional study involved 17,349 newly diagnosed diabetes in adults aged ≥30 years from 46 hospitals within 31 months. Demographic characteristics, clinical features, and medical history were collected by trained researchers. T1DM as a whole was comprised of classic T1DM and LADA. Classic T1DM was identified based on the clinical phenotype of insulin-dependency, and LADA was differentiated from patients with initially an undefined diabetes type with standardized glutamic acid decarboxylase autoantibody testing at the core laboratory. The age and sex distributions from a large national survey of diabetes in China conducted in 2010 were used to standardize the prevalence of classic T1DM and LADA. Results: Among 17,349 adult patients, the prevalence of T1DM was 5.49% (95% CI: 4.90– 6.08%) (5.14% [95% CI: 4.36–5.92%] in males and 6.16% [95% CI: 5.30–7.02%] in females), with 65% of these having LADA. The prevalence of classic T1DM decreased with increasing age (p<0.05), while that of LADAwas stable (p>0.05). The prevalence of T1DM in overweight or obese patients was 3.42% (95% CI: 3.20–3.64%) and 2.42% (95% CI: 1.83–3.01%), respectively, and LADA accounted for 76.5% and 79.2% in these two groups. Conclusion: We draw the conclusion that T1DM, especially LADA, was prevalent in newly diagnosed adult-onset diabetes in China, which highlights the importance of routine islet autoantibodies testing in clinical practice.